Mood disorders in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Tan, Louis C S ^a,b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b USA National Parkinson Foundation Centre of Excellence   (United States)

Author keywords

Anxiety; Apathy; Behaviour; Dementia; Depression; Neuropsychiatry

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; MODAFINIL; NORTRIPTYLINE; OMEGA 3 FATTY ACID; PAROXETINE; PLACEBO; PRAMIPEXOLE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; ANXIETY; ANXIETY DISORDER; APATHY; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; COGNITIVE THERAPY; COPING BEHAVIOR; COUNSELING; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; FATIGUE; FUNCTIONAL DISEASE; GENDER; HUMAN; LEISURE; LOW DRUG DOSE; MAJOR DEPRESSION; MASSAGE; MOOD DISORDER; MOTOR DYSFUNCTION; ONSET AGE; PANIC; PARKINSON DISEASE; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SLEEP DISORDER; SYMPTOM; TRANSCRANIAL MAGNETIC STIMULATION; VITAMIN SUPPLEMENTATION;

EID: 84858640670     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70024-4     Document Type: Review

References (20)

1. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leenjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23(2):183-9.
2. Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009;24:2175-86.
3. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248:151-7.
4. Holroyd S, Currie LJ, Wooten GF. Depression is associated with impairment of ADL, non motor function in Parkinson's disease. Neurology 2005;64:2134-5.
5. Marsh L, McDonald WM, Cummings J, Ravina B, et al. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH work group. Mov Disord 2006;21:148-58.
6. Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, et al. Cognitivebehavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry 2011;168:1066-74.
7. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2010;9:573-80.
8. Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P, et al. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2008;23:850-7.
9. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, et al. A controlled trial of antidepressants in patients with Parkinson's disease and depression. Neurology 2009;72:886-92.
10. Skapinakis P, Bakola E, Salanti G, Lewis G, Kyritsis AP, Mavreas V. Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurology 2010, 10;49.
11. Walsh K, Bennett G. Parkinson's disease and anxiety. Postgrad Med J 2001;77: 89-93.
12. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993;34:465-70.
13. Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003;18: 646-51.
14. Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009;24:1333-8.
15. Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, et al. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism Relat Disord 2011;17:249-54.
16. Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L. Apathy may herald cognitive decline and dementia in Parkinson's disease. Mov Disord 2009;24: 2391-7.
17. Pederson KF, Alves G, Aarsland D, Larsen JP. Occurrence and risk factors for apathy in Parkinson's disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 2009;80:1279-82.
18. Kirsch-Darrow L, Zahodne LB, Marsiske, M, Okun MS, Foote KD, Bowers D. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011;17(3):182-8.
19. Starkstein SE, Merello M, Jorge R, Brockman S, Bruce D, Power B. The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord 2009;24:1211-6.
20. Drijgers RL, Dujardin K, Reijnders JS, Defebvre L, Leentjens AF. Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat Disord 2010;16:656-60.